Witzig, T. E., Reeder, C., Han, J. J., LaPlant, B., Stenson, M., Tun, H. W., . . . Gupta, M. (2015). The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma. Blood.
Trích dẫn kiểu ChicagoWitzig, Thomas E., et al. "The MTORC1 Inhibitor Everolimus Has Antitumor Activity in Vitro and Produces Tumor Responses in Patients With Relapsed T-cell Lymphoma." Blood 2015.
Trích dẫn MLAWitzig, Thomas E., et al. "The MTORC1 Inhibitor Everolimus Has Antitumor Activity in Vitro and Produces Tumor Responses in Patients With Relapsed T-cell Lymphoma." Blood 2015.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.